Breeze Meds vs Embody: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Breeze Meds and Embody are tied at 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Embody for users looking for the lowest entry price with round-the-cloc.
A side-by-side comparison of Breeze Meds and Embody covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#29 of 40Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsEmbody
#31 of 40Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit Embody| Feature | Breeze Meds | Embody |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users looking for the lowest entry price with round-the-clock specialist support |
| Ranking | #29 | #31 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
Our Verdict
Breeze Meds and Embody are closely matched with identical scores of 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to Embody's $299/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support.